What does CBD Life Sciences Inc. do?

CBD Life Sciences Inc. is a public company in the Medicinal Chemicals & Botanical Products industry, incorporated in NV. It is registered with the SEC under CIK 0001776073 and trades on OTC under the ticker CBDL.

How many SEC filings has CBD Life Sciences Inc. made?

CBD Life Sciences Inc. has filed 78 documents with the SEC since 2019. These include annual reports (10-K), quarterly reports (10-Q), current event notices (8-K), and insider transaction disclosures (Form 4).

CBD Life Sciences Inc.

CBDL OTC CIK: 0001776073 Medicinal Chemicals & Botanical Products Inc. in NV

View on SEC.gov →

Overview All Filings Annual Quarterly Insiders

Recent Filings

All 78 filings →

Form	Description	Date
253G2	FORM 253G2	May 19, 2025
QUALIF	—	Mar 19, 2025
CORRESP	—	Mar 18, 2025
UPLOAD	—	Mar 17, 2025
CORRESP	—	Mar 17, 2025
1-A POS	—	Mar 17, 2025
1-A POS	—	Mar 6, 2025
1-U	FORM 1-U	Jan 22, 2025
253G2	253G2	Sep 19, 2024
QUALIF	—	Sep 17, 2024

Insider Transactions

View all →

No insider transactions loaded yet.

About This Profile

This page aggregates all publicly available SEC EDGAR data for CBD Life Sciences Inc.. Financial figures are sourced from XBRL-tagged 10-K annual reports. Insider transactions are sourced from Form 4 filings required within two business days of a transaction.

Key Financials

Financial data not yet loaded.

Details

CIK: 0001776073
Ticker: CBDL
Exchange: OTC
Incorporated: NV
First Filing: 2019
Total Filings: 78

Medicinal Chemicals & Botanical Products rankings →